TEL: 044-952-0102


Stem Cell Market - Growth, Trends, and Forecast (2019 - 2024)

発行 Mordor Intelligence LLP 商品コード 390704
出版日 ページ情報 英文 112 Pages
納期: 2-3営業日
本日の銀行送金レート: 1USD=109.74円で換算しております。
Back to Top
幹細胞の世界市場:成長率、動向および予測(2019年~2024年) Stem Cell Market - Growth, Trends, and Forecast (2019 - 2024)
出版日: 2019年03月01日 ページ情報: 英文 112 Pages




1 イントロダクション

  • 調査の成果
  • 調査の前提条件
  • 調査範囲

2 調査方法

3 エグゼクティブサマリー

4 市場のダイナミクス

  • 市場概況
  • 市場成長要因
    • 臍帯幹細胞についての意識の高まり
    • 幹細胞研究における臨床試験の承認の増加
    • 再生治療の選択肢に対する需要の高まり
    • 慢性疾患に対する治療選択肢を開発するための研究開発イニシアチブの高まり
  • 市場阻害要因
    • 高額な治療
    • 規制上の問題
    • 倫理的および道徳的枠組み
  • 業界の魅力 - ポーターのファイブフォース分析
    • 新規参入者の脅威
    • 買い手/消費者の交渉力
    • 売り手の交渉力
    • 代替製品の脅威
    • 業界内の競合の激しさ

5 市場セグメンテーション

  • 製品タイプ別
    • 成人幹細胞
    • ヒト胚細胞
    • 多能性幹細胞
    • 他の製品タイプ
  • 治療用途別
    • 神経学的障害
    • 整形外科治療
    • 腫瘍疾患
    • 糖尿病
    • 怪我と傷
    • 心血管障害
    • その他の治療用途
  • 治療タイプ別
    • 同種幹細胞療法
    • オートロジック幹細胞療法
    • 同系幹細胞療法
  • バンキングサービスおよび技術別
    • 幹細胞の取得と検査
    • 細胞生成
    • 拡張
    • 二次培養
    • 凍結保存
  • バンキングタイプ別
    • 公的
    • 民間
  • 地理
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

6 競合情勢

  • 企業プロファイル
    • Osiris Therapeutics Inc.
    • Pluristem Therapeutics Inc.
    • Thermo Fisher Scientific
    • Qiagen NV
    • Sigma Aldrich Corporation
    • Becton, Dickinson and Company
    • Stem Cell Technologies Inc.
    • AllCells LLC
    • Miltenyi Biotec
    • International Stem Cell Corporation

7 市場機会および将来動向

Product Code: 47511

Market Overview

The stem cell market is experiencing growth, owing to the increasing number of clinical trials around the world. North America, especially the United States, dominated the number of trials undergoing in stem cell therapies. The United States dominates the market in both the products and banking services segments, holding around 77.4% of the total North American market. However, Asia-Pacific is growing at the highest growth rate. Stem cells are majorly used in regenerative medicine, especially in the field of dermatology. However, oncology is expected to grow at the highest growth rate, due to a large number of pipeline products present for the treatment of tumors or cancers. With the increase in the number of regenerative medicine centers, the stem cell market is also expected to increase in the future.

Stem cells banking is gaining importance with the support of government initiatives. The number of stem cell banks is increasing in developing countries, which is aiding the growth of the market. Also, increasing awareness about stem cell storage among the people has positively affected the market. Currently, the market is not well established in many therapeutic areas and has shown nascent success in history. However, it holds great potential in both the diagnosis and therapeutic fields.

Scope of the Report

The scope of this market is limited to tracking the stem cell market. As per the scope of this report, stem cells are biological cells that can differentiate into other types of cells. Also, various types of stem cells are used for therapeutic purposes.

Key Market Trends

Oncology Disorders Segment is Expected to Exhibit Fastest Growth Rate Over the Forecast Period

Cancer has a major impact on society in the United States and across the world. As per the estimation of National Cancer Institute, in 2018, 1,735,350 new cases of cancer were anticipated to get diagnosed in the United States, and 609,640 deaths were expected from the disease. This increasing medical burden is due to population growth. Bone marrow transplant or stem cell transplant is a treatment for some types of cancers, like leukemia, multiple myeloma, multiple myeloma, neuroblastoma, or some types of lymphoma.

Embryonic stem cells (ESC) are the major source of stem cells for therapeutic purposes, due to their higher totipotency and indefinite lifespan, as compared to adult stem cells with lower totipotency and restricted lifespan. However, the use of ESCs for research and therapeutic purposes is restricted and prohibited in many countries throughout the world, due to some ethical constraints. Scientists from the University of California, Irvine, created the stem cell-based approach to kill cancerous tissue while preventing some toxic side effects of chemotherapy by treating the disease in a more localized way.

Although the market shows positive growth, due to the growing focus of stem cell-based research that can further strengthen the clinical application, its expensive nature for stem cell therapy may still hamper its growth.

North America Captured The Largest Market Share and is Expected to Retain its Dominance

North America dominated the overall stem cell market with the United States contributing to the largest share in the market. In 2014, the Sanford Stem Cell Clinical Center at the University of California, San Diego (UCSD) Health System, announced the launch of a clinical trial, in order to assess the safety of neural stem cell-based therapy in patients with chronic spinal cord injury. Researchers hoped that the transplanted stem cells may develop into new neurons that could replace severed or lost nerve connections, and restore at least some motor and sensory functions. Such numerous stem cell studies across the United States have helped in the growth of the stem cell market.

Competitive Landscape

The stem cell market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. The presence of major market players, such as Thermo Fisher Scientific, Qiagen NV, Sigma Aldrich (A Subsidiary of Merck KGaA), Becton, Dickinson and Company, and Stem Cell Technologies, is in turn, increasing the overall competitive rivalry in the market. The product advancements and improvement in stem cell technology by the major players are increasing the competitive rivalry.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents


  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study




  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increased Awareness about Umbilical Stem Cell
    • 4.2.2 Increase in the Approval for Clinical Trials in Stem Cell Research
    • 4.2.3 Growing Demand for Regenerative Treatment Option
    • 4.2.4 Rising R&D Initiatives to Develop Therapeutic Options for Chronic Diseases
  • 4.3 Market Restraints
    • 4.3.1 Expensive Procedures
    • 4.3.2 Regulatory Complications
    • 4.3.3 Ethical and Moral Framework
  • 4.4 Industry Attractiveness- Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry


  • 5.1 By Product Type
    • 5.1.1 Adult Stem Cell
    • 5.1.2 Human Embryonic Cell
    • 5.1.3 Pluripotent Stem Cell
    • 5.1.4 Other Product Types
  • 5.2 By Therapeutic Application
    • 5.2.1 Neurological Disorders
    • 5.2.2 Orthopedic Treatments
    • 5.2.3 Oncology Disorders
    • 5.2.4 Diabetes
    • 5.2.5 Injuries and Wounds
    • 5.2.6 Cardiovascular Disorders
    • 5.2.7 Other Therapeutic Applications
  • 5.3 By Treatment Type
    • 5.3.1 Allogeneic Stem Cell Therapy
    • 5.3.2 Auto logic Stem Cell Therapy
    • 5.3.3 Syngeneic Stem Cell Therapy
  • 5.4 By Banking Service and Technology
    • 5.4.1 Stem Cell Acquisition and Testing
    • 5.4.2 Cell Production
    • 5.4.3 Expansion
    • 5.4.4 Sub-culture
    • 5.4.5 Cryopreservation
  • 5.5 By Type of Banking
    • 5.5.1 Public
    • 5.5.2 Private
  • 5.6 Geography
    • 5.6.1 North America
      • US
      • Canada
      • Mexico
    • 5.6.2 Europe
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Rest of Europe
    • 5.6.3 Asia-Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • 5.6.4 Middle East & Africa
      • GCC
      • South Africa
      • Rest of Middle East & Africa
    • 5.6.5 South America
      • Brazil
      • Argentina
      • Rest of South America


  • 6.1 Company Profiles
    • 6.1.1 Osiris Therapeutics Inc.
    • 6.1.2 Pluristem Therapeutics Inc.
    • 6.1.3 Thermo Fisher Scientific
    • 6.1.4 Qiagen NV
    • 6.1.5 Sigma Aldrich Corporation
    • 6.1.6 Becton, Dickinson and Company
    • 6.1.7 Stem Cell Technologies Inc.
    • 6.1.8 AllCells LLC
    • 6.1.9 Miltenyi Biotec
    • 6.1.10 International Stem Cell Corporation


Back to Top